Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the Americas

Recombinant protein KR95 as an alternative for serological diagnosis of human visceral leishmaniasis in the Americas

Show other versions (1)

In the Americas, visceral leishmaniasis (VL) is caused by the protozoan Leishmania infantum, leading to death if not promptly diagnosed and treated. In Brazil, the disease reaches all regions, and in 2020, 1,933 VL cases were reported with 9.5% lethality. Thus, an accurate diagnosis is essential to...

Full description

Bibliographic Details
Main Authors: Mahyumi Fujimori, Ruth Tamara Valencia-Portillo, José Angelo Lauletta Lindoso, Beatriz Julieta Celeste, Roque Pacheco de Almeida, Carlos Henrique Nery Costa, Alda Maria da Cruz, Angelita Fernandes Druzian, Malcolm Scott Duthie, Carlos Magno Castelo Branco Fortaleza, Ana Lúcia Lyrio de Oliveira, Anamaria Mello Miranda Paniago, Igor Thiago Queiroz, Steve Reed, Aarthy C. Vallur, Hiro Goto, Maria Carmen Arroyo Sanchez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980733/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980733/?tool=EBI

Similar Items